In English | En español
Questions About Cancer? 1-800-4-CANCER

Page Options

  • Print This Page
  • Email This Document

Office of Advocacy Relations

OAR Banner

Office of Advocacy Relations (OAR)

Latest for Advocates

View the completed scientific frameworks for pancreatic ductal adenocarcinoma (PDAC) and small cell lung cancer (SCLC).

The NCI Office of Advocacy Relations (OAR) serves as a conduit between NCI and the cancer advocacy community. Our office works with individual research advocates, local and national advocacy groups, and professional societies to ensure their perspectives are included in NCI efforts to advance cancer research and improve patient outcomes.
Learn more about research advocacy at NCI
Learn about the role of OAR

How Advocates Advance Research at NCI

NCI is dedicated to engaging the cancer advocacy community and continues to develop and refine ways to involve research advocates in its activities. OAR maintains a diverse network of individuals with varying levels of research advocacy experience, allowing NCI an opportunity to tap into the diverse viewpoints of the cancer community. In addition to participating in various NCI activities, research advocates play a critical role in connecting with their respective constituencies.

Director's Consumer Liaison Group

The Director’s Consumer Liaison Group (DCLG) is the only federal advisory committee comprised of advocate leaders at NCI. DCLG members are chosen for their expert knowledge of issues of importance to the cancer research community. The DCLG focuses on matters that facilitate research and often identifies and responds to challenges facing the Institute at the request of NCI leadership.
Learn more about the DCLG